Chemours Reports Executive Changes and Compensation Arrangements
Ticker: CC · Form: 8-K · Filed: Feb 16, 2024 · CIK: 1627223
| Field | Detail |
|---|---|
| Company | Chemours Co (CC) |
| Form Type | 8-K |
| Filed Date | Feb 16, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $160,000, $105,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, compensatory-arrangements, corporate-governance
TL;DR
**Chemours just filed an 8-K about executive changes and compensation, keep an eye out for details!**
AI Summary
The Chemours Company filed an 8-K on February 16, 2024, reporting an event that occurred on February 12, 2024. The filing pertains to Item 5.02, "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers," and Item 9.01, "Financial Statements and Exhibits." This indicates changes in executive leadership or their compensation, though specific names or dollar amounts are not detailed in the provided text.
Why It Matters
Changes in executive leadership or their compensation can signal strategic shifts, financial performance issues, or new directions for a company, directly impacting investor confidence and future stock performance.
Risk Assessment
Risk Level: medium — The filing indicates changes in leadership or compensation, which can introduce uncertainty or signal underlying issues without further details.
Key Players & Entities
- Chemours Co (company) — Registrant
- February 12, 2024 (date) — Date of Earliest Event Reported
- February 16, 2024 (date) — Filed As Of Date
- Delaware (location) — State of Incorporation
- 1007 Market Street Wilmington, Delaware 19801 (location) — Business Address
FAQ
What is the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 12, 2024.
Which items are reported in this 8-K filing?
This 8-K filing reports on Item 5.02, "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers," and Item 9.01, "Financial Statements and Exhibits."
What is the full legal name of the registrant?
The exact name of the registrant as specified in its charter is The Chemours Company.
What is the business address of The Chemours Company?
The business address of The Chemours Company is 1007 Market Street, Wilmington, Delaware 19801.
When was this 8-K filed with the SEC?
This 8-K was filed with the SEC on February 16, 2024.
Filing Stats: 718 words · 3 min read · ~2 pages · Grade level 11.1 · Accepted 2024-02-16 16:16:11
Key Financial Figures
- $0.01 — nge on Which Registered Common Stock ($0.01 par value) CC New York Stock Exchan
- $160,000 — nual director equity award increased to $160,000 effective April 26, 2023, and the annua
- $105,000 — ual director cash retainer increased to $105,000 effective January 1, 2024. The Company
Filing Documents
- cc-20240212.htm (8-K) — 46KB
- cc-ex99_1.htm (EX-99.1) — 16KB
- img15408389_0.jpg (GRAPHIC) — 37KB
- img172682096_0.jpg (GRAPHIC) — 35KB
- 0000950170-24-016376.txt ( ) — 319KB
- cc-20240212.xsd (EX-101.SCH) — 29KB
- cc-20240212_htm.xml (XML) — 4KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits 99.1 Press Release of the Company, dated as of February 16, 2024. 104 Cover Page Interactive Data File (formatted as Inline XBRL).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CHEMOURS COMPANY By: /s/ Jonathan Lock Jonathan Lock Senior Vice President, Chief Financial Officer Date: February 16, 2024